A unique collaboration with US Special Operations Command
Nearly 300 government and military members participated in a new course designed to explore the next generation of artificial intelligence and related technologies.
Nearly 300 government and military members participated in a new course designed to explore the next generation of artificial intelligence and related technologies.
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
A machine learning model developed jointly by Janssen and MIT data scientists played a key role in the clinical trial process for the Johnson & Johnson Covid-19 vaccine.
Using deep convolutional neural networks, researchers devise a system that quickly analyzes wide-field images of patients’ skin in order to more efficiently detect cancer.
Regina Barzilay, Fotini Christia, and Collin Stultz describe how artificial intelligence and machine learning can support fairness, personalization, and inclusiveness in health care.
MIT conference illustrates technologies developed in response to the pandemic and new opportunities for AI solutions for clinical management.
Research projects will harness the power of artificial intelligence to positively impact human health.
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
A deep-learning model identifies a powerful new drug that can kill many species of antibiotic-resistant bacteria.
A key part of J-Clinic, the MIT-Takeda Program will create educational opportunities and support cutting-edge research to positively impact human health.
Machine learning reveals metabolic pathways disrupted by the drugs, offering new targets to combat resistance.
Projects will develop new AI technologies that detect and prevent diseases.
MITii will hire experts to pursue new business opportunities by matching MIT expertise and innovation with real-world problems.
Deep-learning model has been used successfully on patients, may lead to more consistent screening procedures.
MacArthur “geniuses” in machine learning and synthetic biology to serve as faculty co-leads; Nobel laureate to chair advisory board of new research center.